OncoMed Pharmaceuticals Inc. Product Market Pipeline 2014

1. OncoMed Pharmaceuticals, Inc. - Product Pipeline Review - 2014 www.bigmarketresearch.com

2. Acquired (Autoimmune) Hemolytic Anemia Report Description Summary Global Markets Direct’s, ‘OncoMed Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the OncoMed Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of OncoMed Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get More Details At: http://www.bigmarketresearch.com/oncomed-pharmaceuticals-inc-product-pipeline-review-2014-market

3. Report Description

4. Report Description Scope - The report provides brief overview of OncoMed Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of OncoMed Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the OncoMed Pharmaceuticals, Inc.’s pipeline products Enquire about report- http://www.bigmarketresearch.com/report-enquiry/152198

5. Report Description • Reasons to buy • Evaluate OncoMed Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline • Assess the growth potential of OncoMed Pharmaceuticals, Inc. in its therapy areas of focus • Identify new drug targets and therapeutic classes in the OncoMed Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps • - Develop strategic initiatives by understanding the focus areas of OncoMed Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

6. Report Description • Reasons to buy • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Plan mergers and acquisitions effectively by identifying the most promising pipeline of OncoMed Pharmaceuticals, Inc. • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Explore the dormant and discontinued projects of OncoMed Pharmaceuticals, Inc. and identify potential opportunities in those areas • - Avoid Intellectual Property Rights related issues

7. Table Of Content • List of Tables • List of Figures • OncoMed Pharmaceuticals, Inc. Snapshot • OncoMed Pharmaceuticals, Inc. Overview • Key Information • Key Facts • OncoMed Pharmaceuticals, Inc. - Research and Development Overview • Key Therapeutic Areas • OncoMed Pharmaceuticals, Inc. - Pipeline Review • Pipeline Products by Stage of Development • Pipeline Products - Monotherapy • Pipeline Products - Partnered Products • Get complete TOC here @ http://www.bigmarketresearch.com/oncomed-pharmaceuticals-inc-product-pipeline-review-2014-market

8. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/oncomed-pharmaceuticals-inc-product-pipeline-review-2014-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@bigmarketresearch.com